Best Weight Loss Programs in 2026 — Ranked & Reviewed

Structured weight-loss programs are not interchangeable with telehealth GLP-1 prescribers, weight-loss supplements, or meal-delivery services — they sit at the intersection. Below we rank every program in our directory and explain what categories of program exist, what the published evidence supports, and how programs are increasingly being paired with FDA-approved weight-loss medications in 2026.

Lowest verified price: $60/mo6 providers compared

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed

6 weight loss programs compared · independently scored against our six-factor methodology.

Quick Picks: Top 5

#ProviderScore
1Red Mountain Weight LossVisit
2WeightWatchersVisit
3Hone HealthVisit
4MD Total WellnessVisit
5System LabsVisit

Compare the top providers at a glance

Logos, our editorial rating, price, medications, and coverage — the fastest way to narrow the list.

  • ★ Editor's Pick

    hybrid clinic-plus-telehealth GLP-1 from a 30-year obesity-medicine specialist

    From /mo
    $149
    Coverage
    4 states
    Medications
    SemaglutideTirzepatide
  • WeightWatchers

    Foundayo access with a structured behavior-change program

    From /mo
    $149
    Scales with dose
    Coverage
    Check intake
    Medications
    Orforglipron
  • Best Budget
    Hone Health

    weight management inside a broader hormone and longevity program

    From /mo
    $60
    Coverage
    Check intake
    Medications
    Liraglutide
  • Orange County CA patients seeking in-person GLP-1 access

    From /mo
    $199
    Coverage
    1 states
    Medications
    SemaglutideTirzepatide
  • From /mo
    Check pricing
    Coverage
    Check intake
    Medications
    —
  • Irving/Dallas patients wanting in-person, physician-led weight loss care

    From /mo
    Check pricing
    Coverage
    1 states
    Medications
    —
6scored dimensions
6weight loss programs compared
100%verified against live provider sites
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

Detailed Reviews

1

Red Mountain Weight Loss

Best for: hybrid clinic-plus-telehealth GLP-1 from a 30-year obesity-medicine specialist

7.7

Red Mountain Weight Loss is a hybrid obesity-medicine practice founded in 1995, combining nine physical clinics across Arizona and Texas with telemedicine in four states. Unlike typical telehealth startups, it brings 30 years of history and American Board of Obesity Medicine credentialing, with named physicians leading care. Tiered programs run $199–$599, with compounded GLP-1 starting at $149/month and a $55 initial consultation.

Score Breakdown

Value25%
7
Effectiveness25%
8.5
User Experience15%
7
Trust & Safety15%
9.5
Accessibility10%
5.5
Support10%
7.5

Pros

  • ✓30+ years operating (founded 1995) — a longer run than any other clinic we review
  • ✓Named medical directors (Dr. Suzanne Bentz, D.O., founder; Dr. Shelly Kocher) — uncommon transparency
  • ✓American Board of Obesity Medicine certified — credentialed specialist track
  • ✓LegitScript Approved
  • ✓Hybrid model: 9 physical clinics (7 AZ, 2 TX) plus telemedicine for AZ/TX/OK/FL residents
  • ✓Tiered programs ($149–$599); DirectMed at $149/mo competes with the low end of the compounded market
  • ✓Named pharmacy partner (Nationwide Compounding Rx, Scottsdale AZ) and low $55 initial consult fee

Cons

  • ✗Telemedicine limited to AZ, TX, OK, and FL — residents of the other 46 states can't enroll
  • ✗Non-telemedicine programs require visiting a physical clinic in AZ or TX
  • ✗Higher-tier programs ($599/mo) cost more than the lowest-cost compounded providers ($99–$199/mo)
  • ✗Multiple program tiers (RM3, GLP Elite, DirectMed, Lifestyle) can confuse first-time patients
  • ✗The original RM3 program historically used phentermine + B12 + diet protocol; modern GLP-1 protocols may differ from the branding
2

WeightWatchers

Best for: Foundayo access with a structured behavior-change program

7.6

WeightWatchers offers Foundayo (orforglipron) through its Med+ program, with care delivered by the WeightWatchers Clinic affiliate medical group. Foundayo is self-pay at $149/mo for the starting dose and up to $299/mo at higher doses, billed separately from the Med+ membership ($25 first month, $74/mo after with a 12-month commitment). WW is one of the few non-pharmacy telehealth programs that lists Foundayo transparently.

Score Breakdown

Value25%
7.5
Effectiveness25%
7.5
User Experience15%
7
Trust & Safety15%
8
Accessibility10%
8.5
Support10%
7.5

Pros

  • ✓One of the first non-pharmacy telehealth programs to list Foundayo transparently
  • ✓Care delivered by WeightWatchers Clinic (affiliated medical group)
  • ✓Supports all 6 Foundayo doses: 0.8mg, 2.5mg, 5.5mg, 9mg, 14.5mg, 17.2mg
  • ✓Publishes self-pay drug price on the product page (rare for a telehealth program)
  • ✓Combines pharmacotherapy with the WW Points/behavior-change program

Cons

  • ✗Med+ membership ($25 first month, $74/mo after) is billed on top of the drug cost, so real out-of-pocket tops the listed $149/mo
  • ✗State availability list not published publicly — requires eligibility quiz
  • ✗Insurance coverage for Foundayo not yet available per WW's own disclosure
  • ✗No compounded GLP-1 option; Foundayo only
  • ✗12-month Med+ commitment required to lock the introductory $25 price
3

Hone Health

Best for: weight management inside a broader hormone and longevity program

7.1

Hone Health is a comprehensive longevity telehealth platform for men and women offering hormone optimization, weight management, sexual health, and metabolic health programs. Weight loss formulary includes compounded liraglutide ($160/mo), naltrexone ($60/mo), bupropion ($60/mo), phentermine ($65/mo), topiramate ($65/mo), and sermorelin ($130/mo) — all require a membership ($25/mo Basic or $149/mo Premium).

Score Breakdown

Value25%
6
Effectiveness25%
7
User Experience15%
8
Trust & Safety15%
7.8
Accessibility10%
7
Support10%
7.5

Pros

  • ✓Comprehensive longevity platform — weight loss alongside testosterone, hormone optimization, sexual health, and appearance treatments
  • ✓Now serves both men and women (not men-only as originally positioned)
  • ✓Transparent pricing on weight loss page — all medication costs listed per month
  • ✓Advanced 40+ biomarker lab testing ($65) provides data-driven treatment plans
  • ✓Licensed physicians build personalized protocols with retesting every 90 days
  • ✓Two membership tiers: Basic ($25/mo) and Premium ($155/mo) with cancel-anytime flexibility

Cons

  • ✗Does NOT offer semaglutide or tirzepatide — GLP-1 formulary limited to compounded liraglutide ($160/mo)
  • ✗State availability not publicly disclosed
  • ✗Weight management is one of many verticals — not a GLP-1-specialist funnel
  • ✗No visible LegitScript certification or PCAB accreditation
  • ✗All medication prices are on top of a mandatory membership fee ($25–$155/mo)
4

MD Total Wellness

Best for: Orange County CA patients seeking in-person GLP-1 access

6.9

MD Total Wellness is a wellness clinic in Brea, CA offering semaglutide alongside hormone therapy, skin rejuvenation, and pelvic floor treatments. Local clinic with telehealth capabilities.

Score Breakdown

Value25%
7
Effectiveness25%
7
User Experience15%
7
Trust & Safety15%
7
Accessibility10%
6
Support10%
7

Pros

  • ✓Physical clinic with named address
  • ✓Semaglutide confirmed

Cons

  • ✗Local clinic in Brea, CA — not a nationwide telehealth provider
  • ✗Pricing not publicly available
  • ✗Little program detail is published on the site
5

System Labs

Verified partner
6.9

System Labs (System Laboratories, Inc.) is a US telehealth platform selling peptide and longevity treatments — NAD+, glutathione, sermorelin, and a MIC+B12 lipotropic injection — from licensed US compounding pharmacies. It's LegitScript-certified and HIPAA-compliant, though it doesn't publicly list semaglutide or tirzepatide. The weight-loss-adjacent MIC+B12 injection runs $89/month, with NAD+ and glutathione at $149/month plus intro pricing on most.

Score Breakdown

Value25%
7
Effectiveness25%
7
User Experience15%
7
Trust & Safety15%
6
Accessibility10%
7
Support10%
7.4
How we rank & what counts as “legit”

Every provider in this ranking is scored against our published six-factor rubric[1] — value, effectiveness, user experience, trust & safety, accessibility, and support.

Brand-name Wegovy, Zepbound, Ozempic, and Mounjaro are separately FDA-approved under their own NDA numbers[4][5]. Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[6], and for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) from SURMOUNT-1[7]; the SURMOUNT-5 head-to-head published in 2025 compared the two directly[8].

Insurance coverage for anti-obesity medications varies widely by state Medicaid program and commercial plan[9][10]. Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a prescription under IRS Publication 502[11].

Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

What counts as a weight-loss program in 2026

A “weight-loss program” in 2026 is a structured, multi-component intervention combining at least two of: behavioral coaching, dietary guidance, physical-activity programming, and (increasingly) clinical oversight that may include FDA-approved weight-loss medications. We treat programs as distinct from FDA-approved medications, weight-loss supplements, meal-delivery services, and pure telehealth GLP-1 prescribers — though many modern programs combine elements of several. The categories below clarify where each option sits.

The four categories of structured weight-loss programs

1. Behavioral coaching programs

Examples: WeightWatchers (now WW & ZP), Noom, Found, Calibrate. Lifestyle and behavior change is the primary intervention; some now layer in GLP-1 prescribing as a Pro tier. The Diabetes Prevention Program (DPP) is the canonical NIH-published evidence base for structured behavioral weight-loss programs in adults at risk for type 2 diabetes.

2. Meal-replacement programs

Examples: Optavia, Nutrisystem, Jenny Craig, SlimFast. Pre-portioned meal plans (often high-protein, calorie-controlled) replace some or all daily food. Effective for short-term weight loss in published trials but require sustained behavioral change to maintain results once the meal plan ends.

3. App-based / digital health

Examples: Lose It!, MyFitnessPal Premium, Cronometer, Lifesum. Self-directed calorie / macro / habit tracking with optional coaching. Lowest cost category but also the lowest published efficacy signal for sustained weight loss without additional intervention.

4. GLP-1-paired hybrid programs

Examples: Hone Health, MD Total Wellness, Found (with Rx), Calibrate, the new WeightWatchers Clinic. Bundle clinical GLP-1 prescribing (semaglutide or tirzepatide, brand or compounded) with behavioral coaching, lab work, and structured follow-up. The fastest-growing category in 2026 and where most new entrants are positioning.

Programs and FDA-approved medications: how they fit together in 2026

The published Phase 3 evidence on FDA-approved weight-loss medications (Wegovy in STEP-1, Zepbound in SURMOUNT-1 — both summarized in our FDA-approved weight-loss medications hub and the bariatric vs GLP-1 decision guide) was generated alongside a structured reduced-calorie diet and increased physical activity — not in isolation. Insurance prior-authorization criteria reflect this: both Cigna and Aetna require documented behavioral and dietary modification (3 months for Cigna, 6 months for Aetna) BEFORE approving any GLP-1 for weight management. A well-structured weight-loss program is the most defensible way to satisfy that documentation requirement.

Programs without an FDA-approved-medication component are still useful — many patients lose meaningful weight with behavioral or meal-replacement programs alone, particularly those whose insurance does not cover GLP-1s. But for patients with BMI ≥30 (or ≥27 with comorbidity) seeking sustained weight loss greater than ~5-10% of body weight, the published evidence increasingly supports a paired program-plus-medication approach over either alone.

What to look for when picking a program

  • Clinical oversight if medications are involved. Verify state-licensed prescribers and a published pharmacy partnership. Our semaglutide providers ranking and tirzepatide providers ranking document the clinical infrastructure of each GLP-1-paired program.
  • Cancellation and refund policy. Auto-renewal traps are common. The published cancel flow should be documented and easy to find.
  • Total monthly cost. Beware of program-fee + medication-fee + lab-fee bundling that obscures the headline price. Our live pricing index surfaces the all-in monthly cost for every provider.
  • Provider trust signals. LegitScript accreditation, PCAB pharmacy partner, state-licensed clinicians, transparent ownership/legal entity. Our six-factor methodology evaluates these explicitly.
  • Insurance compatibility. Many programs are cash-pay only, which means no PA letter, no copay savings card, no Part D coverage. See our insurance coverage guide for the per-insurer breakdown.

Frequently Asked Questions

The programs with the best long-term results combine behavioral coaching, a sustainable eating plan, activity guidance, and — increasingly — clinical oversight that can include FDA-approved weight-loss medication when appropriate. The single biggest predictor of success isn't the program brand; it's ongoing support and adherence over months, not weeks.
It depends on what's included. A program that bundles coaching, a structured plan, and (where offered) GLP-1 medication with clinician support can be worth it if you'll use the support; a subscription you don't engage with rarely is. Compare what each program actually includes — and whether medication is add-on or built in — in the ranked list above.
Some do and some don't. A growing number of programs now pair coaching with clinician-prescribed GLP-1s like semaglutide or tirzepatide; others are behavior-and-diet only. The ranking above notes which programs offer medication access so you can match the format to your goals.
Each provider is evaluated across six weighted dimensions: Value (25%), Effectiveness (25%), User Experience (15%), Trust & Safety (15%), Accessibility (10%), and Support (10%). We research publicly available information, user reviews, clinical evidence, and pricing data, then compute a weighted overall score out of 10.
Each provider's score is computed independently using the six-dimension methodology, and a commercial relationship never changes a provider's underlying score — you can see every provider's full score on its card. Some providers have affiliate agreements with us, meaning we earn a commission if you click through and make a purchase. On our highest-commercial-intent lists — including the semaglutide, tirzepatide, compounded and cheapest molecule lists, the weight-loss injection and shot lists, and the fitness-app list — we feature affiliate partners in the top positions; on every other list the order follows the score (or, for the cheapest lists, the lowest price) directly. This placement is disclosed here and on our methodology and affiliate-disclosure pages.
Sources & methodology — as of October 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  5. 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  8. 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
  9. 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  10. 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
  11. 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.